Focusing on anticancer drugs that target Ephexin1, which is mainly found in brain tissue but significantly increased in LC and CRC [19, 20, 22, 24], could offer specificity and effectiveness against cancer cells with minimal impact on normal cells. This evidence concerns the gene NGEF and laryngotracheoesophageal cleft.